Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2017 group results

Feb 14 (Reuters)-  
          Cosmo Bio Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Dec 31, 2017    Dec 31, 2016   Dec 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           7.07            7.43           7.50          3.90     
               (-4.8 pct)      (+1.0 pct)     (+6.1 pct)    (+5.4 pct)  
  Operating      193 mln         514 mln        195 mln      155 mln    
               (-62.5 pct)    (+156.3 pct)    (+1.0 pct)   (-24.9 pct)  
  Recurring      397 mln         483 mln        245 mln      200 mln    
               (-17.8 pct)     (+29.5 pct)    (-38.4 pct)  (-50.0 pct)  
  Net 
  Net            237 mln         254 mln        150 mln      125 mln    
               (-6.5 pct)      (+10.4 pct)    (-37.0 pct)  (-52.8 pct)  
  EPS           40.15 yen       42.93 yen      25.30 yen    21.09 yen   
  Ann Div       14.00 yen       18.00 yen      14.00 yen                
  -Q2 Div       6.00 yen        6.00 yen       6.00 yen                 
  -Q4 Div       8.00 yen        12.00 yen      8.00 yen                 
   
  NOTE - Cosmo Bio Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Cosmo Bio

See all news